300
Participants
Start Date
April 30, 2005
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Ibandronate
Alendronate
GSK Investigational Site, Bennebroek
GSK Investigational Site, Breda
GSK Investigational Site, Damwoude
GSK Investigational Site, Driebergen-Rijsenburg
GSK Investigational Site, Eersel
GSK Investigational Site, Eindhoven
GSK Investigational Site, Enschede
GSK Investigational Site, Etten-Leur
GSK Investigational Site, Geleen
GSK Investigational Site, Groesbeek
GSK Investigational Site, Heerlen
GSK Investigational Site, Hengelo
GSK Investigational Site, Hoogvliet
GSK Investigational Site, Hoogwoud
GSK Investigational Site, Hulst
GSK Investigational Site, Landgraaf
GSK Investigational Site, Losser
GSK Investigational Site, Midwoud
GSK Investigational Site, Nijverdal
GSK Investigational Site, Nunspeet
GSK Investigational Site, Oldebroek
GSK Investigational Site, Oosterend
GSK Investigational Site, Oudenbosch
GSK Investigational Site, Poortvliet
GSK Investigational Site, Prinsenbeek
GSK Investigational Site, Raalte
GSK Investigational Site, Ridderkerk
GSK Investigational Site, Rotterdam
GSK Investigational Site, Spijkenisse
GSK Investigational Site, The Hague
GSK Investigational Site, The Hague
GSK Investigational Site, The Hague
GSK Investigational Site, Tilburg
GSK Investigational Site, Voerendaal
GSK Investigational Site, Wassenaar
GSK Investigational Site, Wildervank
GSK Investigational Site, Woerden
GSK Investigational Site, Zaandam
Lead Sponsor
GlaxoSmithKline
INDUSTRY